Researchers have substantially advanced the development of an new treatment for amyloid heart disease, employing the investigational drug. Early clinical results suggests significant improvements for those affected by a https://biotech614502.izrablog.com/42481796/bridgebio-progresses-cardiac-amyloidosis-therapy-using-the-drug